Transcend Wealth Collective »

Celldex Therapeutics shares owned by Transcend Wealth Collective

Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Transcend Wealth Collective from 13F filings

Historical chart of Transcend Wealth Collective investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by Transcend Wealth Collective consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by Transcend Wealth Collective

Quarter filed Position value Share count Share price at filing
2025-09-30 $239k 9.2k 25.87

More positions owned by Transcend Wealth Collective

Apple Stock (AAPL)
Berkshire Hathaway Inc Del Cl B Stock (BRK.B)
Microsoft Corp Stock (MSFT)
Blue Owl Capital Corporation Cef (OBDC)
Nvidia Corporation Stock (NVDA)
Spdr Portfolio S&p 500 Growth Etf Etf (SPYG)
Invesco Qqq Trust Series I Etf (QQQ)
Merck & Co Stock (MRK)
Spdr S&p 500 Etf Trust Etf (SPY)
Amazon Stock (AMZN)
Blue Owl Capital Inc Com Cl A Stock (OWL)
Vanguard High Dividend Yield Index Etf Etf (VYM)
International Business Machs Stock (IBM)
Jpmorgan Chase & Co Stock (JPM)
Fs Kkr Cap Corp Cef (FSK)

View all positions for Transcend Wealth Collective

Top funds holding Celldex Therapeutics

Kynam Capital Management
Wellington Management Company
BlackRock
FMR
Vanguard Group
Point72 Asset Management
Bellevue Group
Commodore Capital
State Street Corporation
Deep Track Capital
Eventide Asset Management
Geode Capital Management
Polar Capital Holdings
Pictet Asset Management Holding SA
Vestal Point Capital

View all funds holding Celldex Therapeutics